doi:10.3969/j.issn.1673-8640.2015.01.025

Abstract

CLC Number:

R378.1

Figures/Tables 2

References 10

[1]	汪复,朱德妹,胡付品,等.2012年中国CHINET细菌耐药性监测[J].中国感染与化疗杂志,2013,13(5):321-330.
[2]	中华人民共和国卫生部医政司. 全国临床检验操作规程[M].3版.南京:东南大学出版社,2006:736-753.
[3]	Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Twenty-Third Informational Supplement[S].M100-S23,CLSI ,2013.
[4]	孙晴,张正银,郭燕,等.万古霉素耐药肠球菌的检测及分子特征[J].中华传染病杂志,2014,32(5):266-268.
[5]	沈倩燕,沈敏,汤园园.医院感染的病原菌特点及耐药性分析[J].检验医学,2012,27(5):396-399.
[6]	刘丹. 286株肠球菌分布及耐药分析[J].中国当代医药,2013,20(6 ):110-111.
[7]	杨怀德,王玉莲,熊俊芳,等.420株临床分离肠球菌属细菌的耐药性变迁[J].国际检验医学杂志,2014,35(16):2151-2153.
[8]	瞿婷婷,俞云松,孙自镛,等.2011年中国CHINET肠球菌属细菌耐药性监测[J].中国感染与化疗杂志,2013,13(5):337-341.
[9]	HIDRON AI,EDWARDS JR,PATEL J,et a1.NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007[J].Infect Control Hosp Epidemiol,2008,29(11):996-1011.
[10]	朱德妹,汪复,胡付品,等.2010年中国CHINE细菌耐药性监测[J].中国感染与化疗杂志,2011,11(5):321-329.

抗菌药物	2011年		2012年		2013年		合计
抗菌药物	R(%)	S (%)	R(%)	S (%)	R(%)	S (%)	R(%)	S (%)
替加环素	0.0	100.0	0.0	100.0	0.0	100.0	0.0	100.0
万古霉素	0.0	100.0	0.0	100.0	0.0	100.0	0.0	100.0
替考拉宁	0.0	100.0	0.0	100.0	0.0	100.0	0.0	100.0
利奈唑胺	0.0	100.0	0.0	100.0	0.0	100.0	0.0	100.0
呋喃妥因	1.6	94.4	0.0	100.0	0.0	94.9	0.7	96.4
氨苄西林	5.6	94.4	2.9	97.1	2.6	97.4	3.9	96.1
磷霉素	4.0	94.4	9.9	87.9	14.1	79.5	8.5	88.4
氯霉素	21.8	49.2	26.5	42.2	26.0	54.5	24.4	48.2
青霉素	42.1	57.9	47.1	52.9	34.6	65.4	41.8	58.2
高浓度链霉素	52.8	47.2	64.4	35.6	46.2	53.8	54.9	45.1
左旋氧氟沙星	68.3	31.7	67.3	30.7	60.3	37.2	65.9	32.8
高浓度庆大霉素	67.5	32.5	65.7	34.3	65.4	34.6	66.3	33.7
环丙沙星	70.5	28.7	67.6	29.4	61.0	39.0	67.1	31.6
四环素	61.1	38.9	66.7	33.3	78.2	21.8	67.3	32.7
红霉素	79.5	8.2	72.5	9.8	79.5	7.7	77.2	8.6
奎奴普丁-达福普汀	83.6	2.5	86.3	2.9	83.3	6.4	84.4	3.6

抗菌药物	2011年		2012年		2013年		合计
抗菌药物	R(%)	S (%)	R(%)	S (%)	R(%)	S (%)	R(%)	S (%)
替加环素	0.0	100.0	0.0	100.0	0.0	100.0	0.0	100.0
万古霉素	0.0	100.0	0.0	100.0	0.0	100.0	0.0	100.0
替考拉宁	0.0	100.0	0.0	100.0	0.0	100.0	0.0	100.0
利奈唑胺	0.0	100.0	0.0	100.0	0.0	100.0	0.0	100.0
呋喃妥因	1.6	94.4	0.0	100.0	0.0	94.9	0.7	96.4
氨苄西林	5.6	94.4	2.9	97.1	2.6	97.4	3.9	96.1
磷霉素	4.0	94.4	9.9	87.9	14.1	79.5	8.5	88.4
氯霉素	21.8	49.2	26.5	42.2	26.0	54.5	24.4	48.2
青霉素	42.1	57.9	47.1	52.9	34.6	65.4	41.8	58.2
高浓度链霉素	52.8	47.2	64.4	35.6	46.2	53.8	54.9	45.1
左旋氧氟沙星	68.3	31.7	67.3	30.7	60.3	37.2	65.9	32.8
高浓度庆大霉素	67.5	32.5	65.7	34.3	65.4	34.6	66.3	33.7
环丙沙星	70.5	28.7	67.6	29.4	61.0	39.0	67.1	31.6
四环素	61.1	38.9	66.7	33.3	78.2	21.8	67.3	32.7
红霉素	79.5	8.2	72.5	9.8	79.5	7.7	77.2	8.6
奎奴普丁-达福普汀	83.6	2.5	86.3	2.9	83.3	6.4	84.4	3.6

抗菌药物	2011年		2012年		2013年		合计
抗菌药物	R(%)	S (%)	R(%)	S (%)	R(%)	S (%)	R(%)	S (%)
利奈唑胺	0.0	96.4	0.0	98.9	0.0	100.0	0.0	100.0
替加环素	0.9	99.1	1.1	98.9	0.0	100.0	0.8	99.2
替考拉宁	0.0	100.0	0.0	100.0	3.6	96.4	0.8	99.2
万古霉素	0.0	100.0	2.3	97.7	5.2	94.8	2.0	98.0
奎奴普丁-达福普汀	6.5	81.3	2.3	93.2	5.2	89.7	4.7	87.4
氯霉素	3.6	80.9	9.1	71.6	7.1	76.8	6.3	76.8
磷霉素	4.5	90.9	13.4	79.3	16.1	51.8	10.1	78.2
四环素	29.1	70.0	27.3	72.7	34.5	65.5	29.7	69.9
呋喃妥因	33.6	32.7	29.9	31.0	51.7	12.1	36.5	27.5
高浓度庆大霉素	60.9	39.1	47.1	52.9	37.9	62.1	51.0	49.0
高浓度链霉素	64.2	35.8	53.5	46.5	55.2	44.8	58.5	41.5
红霉素	90.6	8.5	79.5	15.9	91.4	5.2	86.9	10.3
氨苄西林	95.5	4.5	96.6	3.4	87.9	12.1	94.1	5.9
青霉素	96.3	3.7	100.0	0.0	89.7	10.3	96.1	3.9
左旋氧氟沙星	96.4	0.9	100.0	0.0	91.4	5.2	96.5	1.6
环丙沙星	97.2	1.9	100.0	0.0	91.2	5.3	96.8	2.0

抗菌药物	2011年		2012年		2013年		合计
抗菌药物	R(%)	S (%)	R(%)	S (%)	R(%)	S (%)	R(%)	S (%)
利奈唑胺	0.0	96.4	0.0	98.9	0.0	100.0	0.0	100.0
替加环素	0.9	99.1	1.1	98.9	0.0	100.0	0.8	99.2
替考拉宁	0.0	100.0	0.0	100.0	3.6	96.4	0.8	99.2
万古霉素	0.0	100.0	2.3	97.7	5.2	94.8	2.0	98.0
奎奴普丁-达福普汀	6.5	81.3	2.3	93.2	5.2	89.7	4.7	87.4
氯霉素	3.6	80.9	9.1	71.6	7.1	76.8	6.3	76.8
磷霉素	4.5	90.9	13.4	79.3	16.1	51.8	10.1	78.2
四环素	29.1	70.0	27.3	72.7	34.5	65.5	29.7	69.9
呋喃妥因	33.6	32.7	29.9	31.0	51.7	12.1	36.5	27.5
高浓度庆大霉素	60.9	39.1	47.1	52.9	37.9	62.1	51.0	49.0
高浓度链霉素	64.2	35.8	53.5	46.5	55.2	44.8	58.5	41.5
红霉素	90.6	8.5	79.5	15.9	91.4	5.2	86.9	10.3
氨苄西林	95.5	4.5	96.6	3.4	87.9	12.1	94.1	5.9
青霉素	96.3	3.7	100.0	0.0	89.7	10.3	96.1	3.9
左旋氧氟沙星	96.4	0.9	100.0	0.0	91.4	5.2	96.5	1.6
环丙沙星	97.2	1.9	100.0	0.0	91.2	5.3	96.8	2.0

[1]	TIAN Yuanyuan, JIA Xiongfei. Advantages and pathogenicity of Enterococci [J]. Laboratory Medicine, 2023, 38(11): 1101-1105.
[2]	KANG Yi, ZHU Hong, SHEN Han, ZHOU Wanqing. Virulence gene analysis of Enterococcus isolated from clinical blood and urine samples [J]. Laboratory Medicine, 2022, 37(11): 1030-1033.
[3]	SUN Gang, SUN Hui, DU Yandan, LI Yinyan, LI Yingzhi, DONG Zhanzhu, TONG Lijun, PENG Bo. Study on the drug resistance and molecular epidemiological characteristics of MRSA in Hulunbuir [J]. Laboratory Medicine, 2021, 36(6): 600-603.
[4]	. [J]. Laboratory Medicine, 2020, 35(1): 37-40.
[5]	MA Bing, WANG Fangfang, WANG Shanmei, ZHANG Jiangfeng, YAN Wenjuan, JING Nan, LI Yi. Performance comparison of 4 panels for in vitro drug susceptibility test of Streptococcus pneumoniae [J]. Laboratory Medicine, 2019, 34(6): 547-550.
[6]	ZHOU Shan, LIU Jiayun, MA Yueyun, ZHOU Ke, ZHOU Lei, HAO Xiaoke, XU Xiuli. Drug resistance and molecular epidemiology of Staphylococcus aureus with suppurative infection [J]. Laboratory Medicine, 2019, 34(2): 140-143.
[7]	CHEN Wenjing, HE Chunyan, YANG Han, ZHAO Huanqiang, CUI Zelin, TANG Rong, LIU Qingzhong. Drug resistance of methicillin-resistant Staphylococcus aureus to mupirocin,fusidic acid and retapamulin [J]. Laboratory Medicine, 2019, 34(1): 33-37.
[8]	CHEN Ye, DONG Yefeng, DONG Deping. Molecular characteristics and drug resistance of Staphylococcus aureus isolated from patients with skin and soft tissue infections in Haian [J]. Laboratory Medicine, 2016, 31(10): 844-847.
[9]	YUAN Ting, YING Chunmei. Molecular epidemiology research of Staphylococcus aureus infection from adult and child patients [J]. Laboratory Medicine, 2015, 30(11): 1119-1124.
[10]	LU Tingyan, SHEN Li, TANG Zhenhua. Evaluation on the efficiency of different media and GBS enrichment broth for GBS detection [J]. Laboratory Medicine, 2015, 30(9): 890-893.
[11]	ZHAO Lingxu, WANG Lei. Primary investigation on in vitro bacteriostatic action of Amur-corktree to Staphylococcus aureus [J]. Laboratory Medicine, 2015, 30(9): 886-889.
[12]	WANG Junrui, WEI Changmei, TA La, CUI Jinghua, DU Xiaoli, HAN Yanqiu. Study on the diversity of in vitro invasion abilities of Staphylococcus aureus clinical isolates with different genotypes [J]. Laboratory Medicine, 2015, 30(7): 740-746.
[13]	NIE Zhiyan, CHEN Xu, CHEN Hong, HAN Lizhong, NI Yuxing. Surveillance on nasal carriage rate and drug resistance of Staphylococcus aureus among 859 youngsters in Shanghai [J]. Laboratory Medicine, 2015, 30(2): 156-159.
[14]	DONG Deping, GU Feifei, CHEN Xu, XIAO Shuzhen, HAN Lizhong, NI Yuxing. Analysis on the molecular characteristics and drug resistance of Staphylococcus aureus isolated from Haian,Jiangsu [J]. , 2014, 29(12): 1234-1237.
[15]	. [J]. , 2014, 29(9): 888-889.

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 2

References 10

Related Articles 15

Recommended Articles

Metrics